Bid opportunityClosing soon
NOI - A Non-Invasive Prognostic Biomarker - Circul
HEALTH AND HUMAN SERVICES, DEPARTMENT OF › NATIONAL INSTITUTES OF HEALTH › NATIONAL INSTITUTES OF HEALTH OLAO
Response deadlineOct 23, 2026 9:00 AM EDT · 6 days left
View official notice on SAM.gov ↗ (opens in a new tab)
Verify before acting. Users must verify deadlines, amendments, attachments, eligibility, and submission requirements on the official SAM.gov notice.
Read the Data Disclaimer.
Key decision factors
- Response deadline
- Oct 23, 2026 9:00 AM EDT · 6 days left
- Posted
- Oct 13, 2026 12:00 AM EDT
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- Not provided or not applicable
- PSC
- Q301 — Reference Laboratory Testing
- Place of performance
- Not specified
- Current status
- Closing soon
Notice details
- Official status
- Closing soon
- Normalized group
- Bid opportunity
- Notice ID
- 66af16818b144456af1ddc0d52fc9378
- Solicitation number
- 75N98027Q00007
Description
Displayed as sanitized plain text from SAM.gov. Retrieved Oct 15, 2026 12:12 AM EDT.
(i)This is a combined synopsis/solicitation for commercial items prepared in accordancewith the format in FAR Subpart 12.6, as supplemented with additional information includedin this notice. This announcement constitutes the only solicitation; proposals are beingrequested, and a separate written solicitation will not be issued. (ii)The solicitation number is 75N98027Q00007. This solicitation is issued as a Notice ofIntent (NOI) for a non-competitive combined synopsis/solicitation to award a contract orpurchase order without providing for full and open competition (including brand-name, ifapplicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to University of Alabama at Birmingham, 701 S 20th Street, Birmingham, AL 35294-0001-0001, for research support to develop and validate circulating cell-free DNA (cfDNA) as a blood-based biomarker of chlorine-induced acute lung injury, using the Matalon Laboratory's sole-source validated murine chlorine inhalation injury model, established mechanistic expertise, access to its actively enrolling aspiration pneumonitis biorepository (human proxy cohort), existing collaborative infrastructure with the NHLBI Laboratory of Precision Omics, and continuity with peer-reviewed federal funding (NIH R01 HL031197). These capabilities are not available from any other source and are essential to the project's feasibility. (iii)The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv)The associated NAICS code is 541380, Testing Laboratories and Services, and the small business size standard is $19.0 million. This requirement is not set aside for small business.
Personalized relevance
Would this fit your company?
Create company profile information with a free account to see a deterministic, explainable relevance score. Matching does not determine eligibility or win probability.
Create Free Account
Pursuit risk (separate from your match score)
Document analysis pending
Some solicitation documents have not been analyzed yet. Additional restrictions may still be present.
Pursuit risk is evaluated separately from your match score above and never changes it. This is not a legal or eligibility determination — verify against the official SAM.gov notice and attachments.